IDH1 and glioblastoma: Although it was first reported by Vogelstein et al. as a WHO-grade 4 glioblastoma; recent analyses have shown that most WHO grade 2 and 3 astrocytoma/oligodendrogliomas are characterized by IDH1/2 mutations [35].